Manganese superoxide dismutase (SOD2/MnSOD)/catalase and SOD2/GPx1 ratios as biomarkers for tumor progression and metastasis in prostate, colon, and lung cancer

Free Radical Biology and Medicine

Volumn 85, Issue , 2015, Pages 45-55

  Miar, Ana ^a,b   Hevia, David ^a,b   Muñoz Cimadevilla, Henar ^a   Astudillo, Aurora ^a,c   Velasco, Julio ^d   Sainz, Rosa M ^a,b   Mayo, Juan C ^a,b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d Hospital de San Agustin   (Spain)

Author keywords

Catalase; Colon cancer; Glutathione; Hydrogen peroxidase; Lung cancer; Peroxidase; Prostate cancer; Redox state; SOD2

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE 1; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL MIGRATION; COLON METASTASIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MANGANESE SUPEROXIDE DISMUTASE GLUTATHIONE PEROXIDASE 1 PROTEIN RATIO; METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE METASTASIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR BIOPSY; TUMOR GROWTH; TUMOR INVASION; WESTERN BLOTTING; CASE CONTROL STUDY; COLON TUMOR; DISEASE COURSE; ENZYMOLOGY; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; PROSTATE TUMOR;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CATALASE; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 84930661800     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.04.001     Document Type: Article

References (70)

1. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W. Coebergh, H. Comber, D. Forman, and F. Bray Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur. J. Cancer 49 2013 1374 1403
2. S. Leo, C. Accettura, and V. Lorusso Castration-resistant prostate cancer: targeted therapies Chemotherapy 57 2011 115 127
3. D.F. Gleason, and G.T. Mellinger Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging J. Urol. 111 1974 58 64
4. Howlader N.N.A., Krapcho M., Garshell J., Neyman N., Altekruse S.F., Kosary C.L., Yu M., Ruhl J., Tatalovich Z., Cho H., Mariotto A., Lewis D.R., Chen H.S., Feuer E.J., Cronin K.A. (eds). SEER Cancer Statistics Review, 1975-2010. http://seer.cancer.gov/scr/1975-2010/. National Cancer Institute. Bethesda, MD; November 2012
5. S.F. Shariat, P.T. Scardino, and H. Lilja Screening for prostate cancer: an update Can J. Urol 15 2008 4363 4374
6. M.R. Jadus, J. Natividad, A. Mai, Y. Ouyang, N. Lambrecht, S. Szabo, L. Ge, N. Hoa, and M.G. Dacosta-Iyer Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention Clin. Dev. Immunol. 2012 2012 160724
7. N.H. Segal, and L.B. Saltz Evolving treatment of advanced colon cancer Annu. Rev. Med 60 2009 207 219
8. J.P. Fruehauf, and F.L. Meyskens Jr. Reactive oxygen species: a breath of life or death? Clin. Cancer Res. 13 2007 789 794
9. A.W. Linnane, and H. Eastwood Cellular redox regulation and prooxidant signaling systems: a new perspective on the free radical theory of aging Ann. N. Y. Acad. Sci. 1067 2006 47 55
10. D. Trachootham, W. Lu, M.A. Ogasawara, R.D. Nilsa, and P. Huang Redox regulation of cell survival Antioxid. Redox Signal. 10 2008 1343 1374
11. S.P. Hussain, L.J. Hofseth, and C.C. Harris Radical causes of cancer Nat. Rev. Cancer 3 2003 276 285
12. J.C. Mayo, D.X. Tan, R.M. Sainz, S. Lopez-Burillo, and R.J. Reiter Oxidative damage to catalase induced by peroxyl radicals: functional protection by melatonin and other antioxidants Free Radic. Res. 37 2003 543 553
13. N.R. Leslie, D. Bennett, Y.E. Lindsay, H. Stewart, A. Gray, and C.P. Downes Redox regulation of PI 3-kinase signalling via inactivation of PTEN EMBO J. 22 2003 5501 5510
14. X. Wang, K.D. McCullough, T.F. Franke, and N.J. Holbrook Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival J. Biol. Chem. 275 2000 14624 14631
15. A. Kowald, and T.B. Kirkwood Accumulation of defective mitochondria through delayed degradation of damaged organelles and its possible role in the ageing of post-mitotic and dividing cells J. Theor. Biol. 202 2000 145 160
16. K.K. Singh Mitochondria damage checkpoint, aging, and cancer Ann. N. Y. Acad. Sci. 1067 2006 182 190
17. C. Kucukgergin, O. Sanli, T. Tefik, M. Aydin, F. Ozcan, and S. Seckin Increased risk of advanced prostate cancer associated with MnSOD Ala-9-Val gene polymorphism Mol. Biol. Rep. 39 2012 193 198
18. C. Mao, L.X. Qiu, P. Zhan, K. Xue, H. Ding, F.B. Du, J. Li, and Q. Chen MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects J. Cancer Res. Clin. Oncol. 136 2010 975 979
19. J. Zejnilovic, N. Akev, H. Yilmaz, and T. Isbir Association between manganese superoxide dismutase polymorphism and risk of lung cancer Cancer Genet. Cytogenet. 189 2009 1 4
20. L. Chaudhuri, A.M. Nicholson, A.L. Kalen, and P.C. Goswami Preferential selection of MnSOD transcripts in proliferating normal and cancer cells Oncogene 31 2012 1207 1216
21. S.K. Dhar, J. Tangpong, L. Chaiswing, T.D. Oberley St, and D.K. Clair Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages Cancer Res. 71 2011 6684 6695
22. K.M. Connor, N. Hempel, K.K. Nelson, G. Dabiri, A. Gamarra, J. Belarmino, L. Van De Water, B.M. Mian, and J.A. Melendez Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells Cancer Res. 67 2007 10260 10267
23. N. Hempel, P.M. Carrico, and J.A. Melendez Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis Anticancer Agents Med. Chem 11 2011 191 201
24. A. Gupta, B. Butts, K.A. Kwei, K. Dvorakova, S.P. Stratton, M.M. Briehl, and G.T. Bowden Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression Cancer Lett. 173 2001 115 125
25. M. Nishikawa, A. Tamada, H. Kumai, F. Yamashita, and M. Hashida Inhibition of experimental pulmonary metastasis by controlling biodistribution of catalase in mice Int. J. Cancer 99 2002 474 479
26. K.K. Nelson, A.C. Ranganathan, J. Mansouri, A.M. Rodriguez, K.M. Providence, J.L. Rutter, K. Pumiglia, J.A. Bennett, and J.A. Melendez Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis Clin. Cancer Res. 9 2003 424 432
27. K. Ishii, L.X. Zhen, D.H. Wang, Y. Funamori, K. Ogawa, and K. Taketa Prevention of mammary tumorigenesis in acatalasemic mice by vitamin E supplementation Jpn. J. Cancer Res. 87 1996 680 684
28. I. Quiros-Gonzalez, R.M. Sainz, D. Hevia, and J.C. Mayo MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells Free Radic. Biol. Med. 2010
29. I. Quiros, R.M. Sainz, D. Hevia, O. Garcia-Suarez, A. Astudillo, M. Rivas, and J.C. Mayo Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells Int. J. Cancer 125 2009 1497 1504
30. C. Lepage, A.M. Bouvier, and J. Faivre Endocrine tumours: epidemiology of malignant digestive neuroendocrine tumours Eur. J. Endocrinol. 168 2013 R77 R83
31. P. Grabowski, J. Schonfelder, G. Ahnert-Hilger, H.D. Foss, H. Stein, G. Berger, M. Zeitz, and H. Scherubl Heterogeneous expression of neuroendocrine marker proteins in human undifferentiated carcinoma of the colon and rectum Ann. N. Y. Acad. Sci. 1014 2004 270 274
32. E. Costa Rama, J. Biscay, M.B. Gonzalez Garcia, A. Julio Reviejo, J.M. Pingarron Carrazon, and A. Costa Garcia Comparative study of different alcohol sensors based on screen-printed carbon electrodes Anal. Chim. Acta 728 2012 69 76
33. M. Chicharro, A. Zapardiel, E. Bermejo, M. Moreno, and E. Madrid Electrocatalytic amperometric determination of amitrole using a cobalt-phthalocyanine-modified carbon paste electrode Anal. Bioanal. Chem. 373 2002 277 283
34. W.A. Sakr, M.V. Tefilli, D.J. Grignon, M. Banerjee, J. Dey, E.L. Gheiler, R. Tiguert, I.J. Powell, and D.P. Wood Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival Urology 56 2000 730 734
35. O. Alenda, G. Ploussard, P. Mouracade, E. Xylinas, A. de la Taille, Y. Allory, D. Vordos, A. Hoznek, C.C. Abbou, and L. Salomon Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors World J. Urol. 29 2011 671 676
36. D.E. Handy, and J. Loscalzo Redox regulation of mitochondrial function Antioxid. Redox Signal. 16 2012 1323 1367
37. S. Pervaiz, and M.V. Clement Superoxide anion: oncogenic reactive oxygen species? Int. J. Biochem. Cell Biol. 39 2007 1297 1304
38. M. Takahashi Oxidative stress and redox regulation on in vitro development of mammalian embryos J. Reprod. Dev. 58 2012 1 9
39. Y. Zhao, Y. Xue, T.D. Oberley, K.K. Kiningham, S.M. Lin, H.C. Yen, H. Majima, J. Hines St, and D. Clair Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model Cancer Res. 61 2001 6082 6088
40. D. Robbins, J.A. Wittwer, S. Codarin, M.L. Circu, T.Y. Aw, T.T. Huang, H. Vanremmen, A. Richardson, D.B. Wang, S.N. Witt, R.L. Klein, and Y. Zhao IDH1 is downregulated during early skin tumorigenesis which can be inhibited by overexpression of MnSOD Cancer Sci. 2012
41. L. Termini, A.L. Filho, P.C. Maciag, D. Etlinger, V.A. Alves, S. Nonogaki, F.A. Soares, and L.L. Villa Deregulated expression of superoxide dismutase-2 correlates with different stages of cervical neoplasia Dis. Markers 30 2011 275 281
42. G. Ray, S. Batra, N.K. Shukla, S. Deo, V. Raina, S. Ashok, and S.A. Husain Lipid peroxidation, free radical production and antioxidant status in breast cancer Breast Cancer Res. Treat. 59 2000 163 170
43. E. Tsanou, E. Ioachim, E. Briasoulis, K. Damala, A. Charchanti, V. Karavasilis, N. Pavlidis, and N.J. Agnantis Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma Histol. Histopathol. 19 2004 807 813
44. R. Izutani, M. Katoh, S. Asano, H. Ohyanagi, and K. Hirose Enhanced expression of manganese superoxide dismutase mRNA and increased TNFalpha mRNA expression by gastric mucosa in gastric cancer World J. Surg. 20 1996 228 233
45. A. Satomi, S. Murakami, T. Hashimoto, K. Ishida, M. Matsuki, and M. Sonoda Significance of superoxide dismutase (SOD) in human colorectal cancer tissue: correlation with malignant intensity J. Gastroenterol. 30 1995 177 182
46. Y. Toh, S. Kuninaka, T. Oshiro, Y. Ikeda, H. Nakashima, H. Baba, S. Kohnoe, T. Okamura, M. Mori, and K. Sugimachi Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas Int. J. Oncol. 17 2000 107 112
47. M. Skrzycki, M. Majewska, M. Podsiad, and H. Czeczot Expression and activity of superoxide dismutase isoenzymes in colorectal cancer Acta Biochim. Pol. 56 2009 663 670
48. J. Chung-man Ho, S. Zheng, S.A. Comhair, C. Farver, and S.C. Erzurum Differential expression of manganese superoxide dismutase and catalase in lung cancer Cancer Res. 61 2001 8578 8585
49. P.M. Chen, Y.H. Wu, M.C. Li, Y.W. Cheng, C.Y. Chen, and H. Lee MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in Lung Adenocarcinomas Mol. Cancer Res. 2012
50. C. Echiburu-Chau, D. Roy, and G.M. Calaf Metastatic suppressor CD44 is related with oxidative stress in breast cancer cell lines Int. J. Oncol. 39 2011 1481 1489
51. M. Wang, J.S. Kirk, S. Venkataraman, F.E. Domann, H.J. Zhang, F.Q. Schafer, S.W. Flanagan, C.J. Weydert, D.R. Spitz, G.R. Buettner, and L.W. Oberley Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor Oncogene 24 2005 8154 8166
52. Z. Kattan, V. Minig, P. Leroy, M. Dauca, and P. Becuwe Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells Breast Cancer Res. Treat. 108 2008 203 215
53. H.J. Zhang, W. Zhao, S. Venkataraman, M.E. Robbins, G.R. Buettner, K.C. Kregel, and L.W. Oberley Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species J. Biol. Chem. 277 2002 20919 20926
54. P.C. Hart, M. Mao, A.L. de Abreu, K. Ansenberger-Fricano, D.N. Ekoue, D. Ganini, A. Kajdacsy-Balla, A.M. Diamond, R.D. Minshall, M.E. Consolaro, J.H. Santos, and M.G. Bonini MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer Nat. Commun 6 2015 6053
55. L. Behrend, A. Mohr, T. Dick, and R.M. Zwacka Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells Mol. Cell. Biol. 25 2005 7758 7769
56. W.D. Travis, R.I. Linnoila, M.G. Tsokos, C.L. Hitchcock, G.B. Cutler Jr, L. Nieman, G. Chrousos, H. Pass, and J. Doppman Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases Am. J. Surg. Pathol. 15 1991 529 553
57. W.D. Travis Advances in neuroendocrine lung tumors Ann. Oncol. 21 Suppl. 7 2010 vii65 vii71
58. J.J. Stuart, L.A. Egry, G.H. Wong, and R.L. Kaspar The 3′ UTR of human MnSOD mRNA hybridizes to a small cytoplasmic RNA and inhibits gene expression Biochem. Biophys. Res. Commun. 274 2000 641 648
59. Y. Xu, F. Fang, J. Zhang, S. Josson, W.H. St Clair, and D.K. St Clair miR-17∗suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes PLoS One 5 2010 e14356
60. S. Kamarajugadda, Q. Cai, H. Chen, S. Nayak, J. Zhu, M. He, Y. Jin, Y. Zhang, L. Ai, S.S. Martin, M. Tan, and J. Lu Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis Cell Death Dis. 4 2013 e504
61. Z. Liu, Q. He, X. Ding, T. Zhao, L. Zhao, and A. Wang SOD2 is a C-myc target gene that promotes the migration and invasion of tongue squamous cell carcinoma involving cancer stem-like cells Int. J. Biochem. Cell Biol. 60 2015 139 146
62. H. Kinugasa, K.A. Whelan, K. Tanaka, M. Natsuizaka, A. Long, A. Guo, S. Chang, S. Kagawa, S. Srinivasan, M. Guha, K. Yamamoto, D.K. St Clair, N.G. Avadhani, J.A. Diehl, and H. Nakagawa Mitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expression Oncogene 2015
63. L. Chaiswing, W. Zhong, and T.D. Oberley Increasing discordant antioxidant protein levels and enzymatic activities contribute to increasing redox imbalance observed during human prostate cancer progression Free Radic. Biol. Med. 2013
64. F. Yamakura, and H. Kawasaki Post-translational modifications of superoxide dismutase Biochim. Biophys. Acta 1804 2010 318 325
65. D.G. Bostwick, E.E. Alexander, R. Singh, A. Shan, J. Qian, R.M. Santella, L.W. Oberley, T. Yan, W. Zhong, X. Jiang, and T.D. Oberley Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer Cancer 89 2000 123 134
66. P.M. Chen, T.C. Wu, Y.C. Wang, Y.W. Cheng, G.T. Sheu, C.Y. Chen, and H. Lee Activation of NF-kappaB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKbeta expression Carcinogenesis 34 2013 2655 2663
67. C.J. Best, J.W. Gillespie, Y. Yi, G.V. Chandramouli, M.A. Perlmutter, Y. Gathright, H.S. Erickson, L. Georgevich, M.A. Tangrea, P.H. Duray, S. Gonzalez, A. Velasco, W.M. Linehan, R.J. Matusik, D.K. Price, W.D. Figg, M.R. Emmert-Buck, and R.F. Chuaqui Molecular alterations in primary prostate cancer after androgen ablation therapy Clin. Cancer Res. 11 2005 6823 6834
68. N. Sharifi, E.M. Hurt, S.B. Thomas, and W.L. Farrar Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer Clin. Cancer Res. 14 2008 6073 6080
69. R. Thomas, and N. Sharifi SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer Mol. Cancer Ther 11 2012 87 97
70. Z. Liu, S. Li, Y. Cai, A. Wang, Q. He, C. Zheng, T. Zhao, X. Ding, and X. Zhou Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling Free Radic. Biol. Med. 53 2012 44 50